Stocktwits on MSN
CMPS stock is breaking out again — retail traders think a major FDA catalyst is brewing
Michael Davis was appointed as the acting head of the FDA’s Center for Drug Evaluation and Research. ・Davis previously served as chief medical officer at Usona Institute, where he helped advance ...
View COMPASS Pathways Plc Sponsored ADR CMPS stock quote prices, financial information, real-time forecasts, and company news from CNN.
Investor's Business Daily on MSN
This psychedelics stock just keeps getting hotter; why shares bypassed a profit-taking zone
Compass Pathways surged Monday on growing enthusiasm for the company's psilocybin-based approach to treatment-resistant ...
Recent attention on COMPASS Pathways (CMPS) centers on its first quarter 2026 earnings and a series of key regulatory steps for COMP360 in treatment resistant depression, including a rolling FDA New ...
We have seen 64 institutional investors add shares of $CMPS stock to their portfolio, and 64 decrease their positions in their most recent quarter.
We have seen 62 institutional investors add shares of $CMPS stock to their portfolio, and 45 decrease their positions in their most recent quarter.
COMPASS Pathways plc (NASDAQ:CMPS) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds. COMPASS Pathways plc (NASDAQ:CMPS) is given fourth position on our list of most promising ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results